Global Balloon Kyphoplasty Market Growth (Status and Outlook) 2023-2029

Global Balloon Kyphoplasty Market Growth (Status and Outlook) 2023-2029

VCF is characterized by the collapse of one or more vertebral bodies, resulting in persistent and unbearable pain in patients. Osteoporosis, a degenerative bone disease, is a leading cause of VCF among elderly women. Metastatic bone disease, multiple myeloma, metastatic spinal tumors, and traumatic injuries also cause VCF. Individuals with VCF can undergo vertebroplasty and kyphoplasty to rectify the condition. Both procedures are minimally invasive and conducted on an outpatient basis. They include the insertion of special bone needles through the tissues in the posterior wall on the back and the injection of orthopaedic cement into the vertebral body. The usage of balloon devices makes kyphoplasty stand apart from vertebroplasty. The gradual inflation of balloon and insertion of devices help restore the pre-facture shape and height of the vertebral bodies. The kyphoplasty procedures lead to the long-term maintenance of spinal bones injured by compression fractures. This procedure reduces pain in individuals; lessens the need for pain medications; decreases dependence on canes or other supporting devices; and helps return to a relatively normal level of physical activity.

LPI (LP Information)' newest research report, the “Balloon Kyphoplasty Industry Forecast” looks at past sales and reviews total world Balloon Kyphoplasty sales in 2022, providing a comprehensive analysis by region and market sector of projected Balloon Kyphoplasty sales for 2023 through 2029. With Balloon Kyphoplasty sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Balloon Kyphoplasty industry.

This Insight Report provides a comprehensive analysis of the global Balloon Kyphoplasty landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Balloon Kyphoplasty portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Balloon Kyphoplasty market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Balloon Kyphoplasty and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Balloon Kyphoplasty.

The global Balloon Kyphoplasty market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

According to the report, osteoporosis is characterized by the loss of bone density and the thinning of bone tissues in the body. The disease accounts for about 85% of overall VCF cases. In the US, 50% of women and 25% of men suffer from osteoporosis-related fractures. About eight million women have osteoporosis, and about 22 million are at risk of developing the disease. Around 700,000 vertebral body fractures are diagnosed annually in the US, with 115,000 being admitted to hospitals for treatment. At least one in two women and one in four men in the US suffer from osteoporosis-related fractures.

This report presents a comprehensive overview, market shares, and growth opportunities of Balloon Kyphoplasty market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Chronic Pain
Spinal Deformity

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CareFusion
DePuy Synthes
Medtronic
Stryker

Please note: The report will take approximately 2 business days to prepare and deliver.